Healthcare provider profile · identity verified

Andrea Radebold, MD

Internal Medicine · BRANFORD, CT · NPI 1942264288

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	523	129
Levothyroxine Sodium	Levothyroxine Sodium	417	103
Lisinopril	Lisinopril	334	80
Rosuvastatin Calcium	Rosuvastatin Calcium	287	82
Amlodipine Besylate	Amlodipine Besylate	277	69
Losartan Potassium	Losartan Potassium	237	63
Gabapentin	Gabapentin	218	34
Escitalopram Oxalate	Escitalopram Oxalate	181	49
Hydrochlorothiazide	Hydrochlorothiazide	157	40
Montelukast Sodium	Montelukast Sodium	153	37
Metformin Hcl	Metformin Hcl	144	46
Alprazolam	Alprazolam	141	36
Furosemide	Furosemide	130	37
Metoprolol Succinate	Metoprolol Succinate	130	36
Eliquis	Apixaban	125	21
Simvastatin	Simvastatin	118	26
Pantoprazole Sodium	Pantoprazole Sodium	114	36
Ezetimibe	Ezetimibe	105	26
Pravastatin Sodium	Pravastatin Sodium	95	29
Trazodone Hcl	Trazodone Hcl	95	27
Lorazepam	Lorazepam	94	28
Allopurinol	Allopurinol	93	23
Diazepam	Diazepam	93	28
Omeprazole	Omeprazole	91	21
Ozempic	Semaglutide	91	13
Zolpidem Tartrate	Zolpidem Tartrate	90	25
Clonazepam	Clonazepam	77	16
Albuterol Sulfate Hfa	Albuterol Sulfate	76	35
Atenolol	Atenolol	74	16
Tramadol Hcl	Tramadol Hcl	73	13
Celecoxib	Celecoxib	69	19
Duloxetine Hcl	Duloxetine Hcl	67	14
Glipizide	Glipizide	66	15
Sertraline Hcl	Sertraline Hcl	65	21
Metoprolol Tartrate	Metoprolol Tartrate	64	16
Bupropion Xl	Bupropion Hcl	63	16
Alendronate Sodium	Alendronate Sodium	58	14
Tamsulosin Hcl	Tamsulosin Hcl	56	15
Amitriptyline Hcl	Amitriptyline Hcl	55	suppressed
Potassium Chloride	Potassium Chloride	55	13
Fluticasone Propionate	Fluticasone Propionate	54	13
Synthroid	Levothyroxine Sodium	54	11
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Farxiga	Dapagliflozin Propanediol	47	12
Pregabalin	Pregabalin	47	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	47	19
Trulicity	Dulaglutide	46	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	31
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Cephalexin	Cephalexin	42	26
Doxycycline Hyclate	Doxycycline Hyclate	42	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Meloxicam	Meloxicam	40	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	12
Xarelto	Rivaroxaban	37	suppressed
Azithromycin	Azithromycin	36	27
Mirtazapine	Mirtazapine	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Famotidine	Famotidine	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Lidocaine	Lidocaine	31	suppressed
Colchicine	Colchicine	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Nystatin	Nystatin	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Hydrocortisone	Hydrocortisone	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Rizatriptan	Rizatriptan Benzoate	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Rivastigmine	Rivastigmine	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Methylprednisolone	Methylprednisolone	23	11
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Livalo	Pitavastatin Calcium	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Baclofen	Baclofen	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Methocarbamol	Methocarbamol	19	13
Enalapril Maleate	Enalapril Maleate	18	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Valsartan	Valsartan	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Zolmitriptan	Zolmitriptan	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Risperidone	Risperidone	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Prednisone	Prednisone	11	suppressed
Zithromax	Azithromycin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error